4.8 Article

BMI1 regulates PRC1 architecture and activity through homo- and hetero-oligomerization

Journal

NATURE COMMUNICATIONS
Volume 7, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ncomms13343

Keywords

-

Funding

  1. National Institute of Health (NIH) [R01 CA181185, R01 CA160467, R01 CA201204, R01 CA134604]
  2. American Cancer Society [RSG-11-082-01-DMC, RSG-13-130-01-CDD]
  3. Leukemia and Lymphoma Society [1340-17, 1215-14]
  4. US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]
  5. Michigan Economic Development Corporation
  6. Michigan Technology Tri-Corridor [085P1000817]

Ask authors/readers for more resources

BMI1 is a core component of the polycomb repressive complex 1 (PRC1) and emerging data support a role of BMI1 in cancer. The central domain of BMI1 is involved in protein-protein interactions and is essential for its oncogenic activity. Here, we present the structure of BMI1 bound to the polyhomeotic protein PHC2 illustrating that the central domain of BMI1 adopts an ubiquitin-like (UBL) fold and binds PHC2 in a beta-hairpin conformation. Unexpectedly, we find that the UBL domain is involved in homo-oligomerization of BMI1. We demonstrate that both the interaction of BMI1 with polyhomeotic proteins and homo-oligomerization via UBL domain are necessary for H2A ubiquitination activity of PRC1 and for clonogenic potential of U2OS cells. Here, we also emphasize need for joint application of NMR spectroscopy and X-ray crystallography to determine the overall structure of the BMI1-PHC2 complex.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available